OmniScience Pharmaceuticals Overview
- Year Founded
-
1999
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
- Investments
-
1
OmniScience Pharmaceuticals General Information
Description
Provider of bio-pharmaceutical research and development services. The company discovers bio-medicinal drug and develops of natural product like compounds.
Contact Information
Website
www.omnipharm.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Pharmaceuticals
Acquirer
Primary Office
- Rochester, NY
- United States
OmniScience Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
OmniScience Pharmaceuticals Patents
OmniScience Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-6875582-B1 | Identifying drug resistant microorganisms and mechanisms of evolution; improving antitumor and bactericidal agents | Inactive | 19-Aug-1999 | 00000000000 | 00 |
| AU-7882800-A | Methods and targets of antibiotic resistance | Inactive | 19-Aug-1999 | 00000000 | |
| EP-1210450-A1 | Methods and targets of antibiotic resistance | Inactive | 19-Aug-1999 | 00000000 | |
| EP-1210450-A4 | Methods and targets of antibiotic resistance | Inactive | 19-Aug-1999 | 00000000 | 0 |
| AU-6916900-A | Gene cloning | Inactive | 19-Aug-1999 | C12N15/1093 |
OmniScience Pharmaceuticals Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000 0000000 0 | 15-May-2020 | 00000 0000 | 0000 | Laboratory Services (Healthcare) |
OmniScience Pharmaceuticals Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 000 0000000 000000 | 15-May-2020 | 00000 00000 00 | 0000 | Completed |
|